news 
Bioptimus Raises $41 Million to Develop a ‘GPT for Biology’
French AI startup Bioptimus has secured a massive $41 million in funding to create a groundbreaking “GPT for biology” model. This innovative approach aims to revolutionize the healthcare sector by leveraging cutting-edge AI technology.
In an exclusive interview, Bioptimus’ CEO emphasized that building foundational models is not part of their roadmap at parent company Owkin. Instead, they have chosen to spin off this project as a standalone entity, allowing them to focus on developing and refining their unique offering.
The funds will be used to bolster the AI platform by incorporating diverse data sources covering broader therapeutic areas. Additionally, the company plans to forge new partnerships with pharmaceutical and biotech companies to expand its reach in the healthcare industry.
Bioptimus has already made a significant impact by launching H-Optimus-0, an open-source foundation model for pathology, which utilizes millions of images to aid in disease diagnosis and research.
Source: techcrunch.com
